The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications

Simon Langdon; Dana Faratian; Charlie Gourley; David Harrison; In Hwa Um; John Smyth

The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications

Simon Langdon, Dana Faratian, Charlie Gourley, David Harrison, In Hwa Um, John Smyth

School of Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Original language	English
Title of host publication	Aromatase inhibitors: Types, Mode of Action and Indications
Publisher	Nova Science Pub Incorporated
Pages	163-174
Number of pages	12
ISBN (Print)	9781607417118
Publication status	Published - 2009

Publication series

Name	Cancer Etiology, Diagnosis and Treatment Series

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Langdon, S., Faratian, D., Gourley, C., Harrison, D., Um, I. H., & Smyth, J. (2009). The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications. In Aromatase inhibitors: Types, Mode of Action and Indications (pp. 163-174). (Cancer Etiology, Diagnosis and Treatment Series). Nova Science Pub Incorporated.

Langdon, Simon ; Faratian, Dana ; Gourley, Charlie et al. / The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors : Aromatase inhibitors: Types, Mode of Action and Indications. Aromatase inhibitors: Types, Mode of Action and Indications. Nova Science Pub Incorporated, 2009. pp. 163-174 (Cancer Etiology, Diagnosis and Treatment Series).

@inbook{f765720b492745faaf63d6ab6ac92dbb,

title = "The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications",

author = "Simon Langdon and Dana Faratian and Charlie Gourley and David Harrison and Um, \{In Hwa\} and John Smyth",

note = "M1 - Chapter (peer-reviewed)",

year = "2009",

language = "English",

isbn = "9781607417118",

series = "Cancer Etiology, Diagnosis and Treatment Series",

publisher = "Nova Science Pub Incorporated",

pages = "163--174",

booktitle = "Aromatase inhibitors: Types, Mode of Action and Indications",

}

Langdon, S, Faratian, D, Gourley, C, Harrison, D , Um, IH & Smyth, J 2009, The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications. in Aromatase inhibitors: Types, Mode of Action and Indications. Cancer Etiology, Diagnosis and Treatment Series, Nova Science Pub Incorporated, pp. 163-174.

The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications. / Langdon, Simon; Faratian, Dana; Gourley, Charlie et al.
Aromatase inhibitors: Types, Mode of Action and Indications. Nova Science Pub Incorporated, 2009. p. 163-174 (Cancer Etiology, Diagnosis and Treatment Series).

Research output: Chapter in Book/Report/Conference proceeding › Chapter

TY - CHAP

T1 - The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors

T2 - Aromatase inhibitors: Types, Mode of Action and Indications

AU - Langdon, Simon

AU - Faratian, Dana

AU - Gourley, Charlie

AU - Harrison, David

AU - Um, In Hwa

AU - Smyth, John

N1 - M1 - Chapter (peer-reviewed)

PY - 2009

Y1 - 2009

UR - http://books.google.co.uk/books?id=YXRyPgAACAAJ

UR - https://www.scopus.com/pages/publications/84892026626

M3 - Chapter

SN - 9781607417118

T3 - Cancer Etiology, Diagnosis and Treatment Series

SP - 163

EP - 174

BT - Aromatase inhibitors: Types, Mode of Action and Indications

PB - Nova Science Pub Incorporated

ER -

Langdon S, Faratian D, Gourley C, Harrison D , Um IH, Smyth J. The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications. In Aromatase inhibitors: Types, Mode of Action and Indications. Nova Science Pub Incorporated. 2009. p. 163-174. (Cancer Etiology, Diagnosis and Treatment Series).

The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications

Publication series

UN SDGs

Other files and links

Cite this